ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2769

A Single Center Experience of Temporal Artery Biopsies Performed in 30 African American Patients

Ammar Haikal1, Garth Fraga2, Jason Springer1 and Mehrdad Maz3, 1Department of Internal Medicine, The University of Kansas Medical Center, Division of Allergy, Clinical Immunology & Rheumatology, Kansas City, KS, 2The University of Kansas Medical Center, Department of Pathology and Laboratory Medicine, Kansas City, KS, 3Allergy, Clinical Immunology, and Rheumatology, Division of Allergy, Clinical Immunology and Rheumatology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: African-Americans, biopsies, giant cell arteritis and temporal arteritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Vasculitis Poster III: Immunosuppressive Therapy in Giant Cell Arteritis and Polymyalgia Rheumatica

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Giant cell arteritis (GCA) is a systemic vasculitis of large and medium-sized arteries mostly reported in Caucasians (CCs) over 50 y.o. There is limited data in the literature on the incidence of GCA in patients of African descent. Here, we review the incidence of GCA based on temporal artery (TA) biopsies in a comparatively large cohort of African-American (AA) patients.

Methods: This is a retrospective chart review of patients (pts) who underwent TA biopsies (TABs) for suspicion of GCA between 1/1/1997 and 1/31/2018 at a tertiary medical center in USA. Cases were identified by searching the pathology database at our institution. Terms used in the search included temporal artery, temporal arteritisa, giant cell arteritis, and borderline arteritis. Self-reported demographics were obtained from the charts. Glass slides from 2 AA pts with a positive pathology report for GCA were reviewed by a pathologist to confirm positivity based on histopathologic features for GCA. Comparisons were made with Fisher Exact Test, using two-tailed test with < 0.05 considered significant.

Results: 200 pts with TABs were identified (Table 1). Of these 30/200 (15%) were AA with a total of 33 TABs (3 bilateral). The median age of diagnosis was 66.5 (range 45-90), and 23/30 (75.66%) were female. Although 2/30 (6.7%) were originally reported as positive for GCA, upon review by the pathologist, one was consistent with small vessel vasculitis with fibrinoid necrosis, and the other did not have histopathologic features of GCA. In contrast, 25/155 (16%) CC pts had positive TABs with a median age of 76 (range 56 – 87) and 98/155 (63.22%) were female.  The remaining 15/200 pts were of other ethnicities of whom 2 had positive TABs. GCA was less frequent in AAs than CCs based on TAB (P=0.0163). Only 3 AAs were seen by a rheumatologist before biopsy as most of the biopsies of AA pts were requested by ophthalmologists, neurologists and primary care physicians. Reasons for biopsy referral among AAs were headache; 24/26 (92%), Scalp tenderness; 9/17 (53%), jaw claudication; 3/13 (23%), and vision loss; 6/21 (28.6%). 14/25 (56%) AA pts had ESR > 50 mm/hr, and 19/22 (86.4%) met 3/5 ACR classification criteria for GCA.

Conclusion: This is one of the largest reported case series in the literature of TA biopsies (TABs) performed in patients of African descent in a single institution in North America. Pathological features of GCA were not present in any TABs in this cohort of 30 African-American (AA) pts.  Our data correlates with the clinical observation that GCA usually presents in Caucasians and is rare in AAs.  The suspicion and diagnosis of GCA should be made with caution in AA pts. Awareness of this among other specialists and primary care physicians may reduce the need for performing unnecessary TABs.

TABLE 1

Ethnicity

Number of patients with Temporal artery biopsy (total 200)

Median Age at biopsy (range)

Female Gender (F)/total (%)

Biopsy consistent with GCA N/(%)

P-Value by Fisher Test

(compared to Caucasians)

Caucasians

155

76 (56 – 87)

98/155 (63.22%)

25/155 (16%)

REF

African-Americans

30

66.5 (45 – 90)

23/30 (75.66%)

0/30 (0%)

0.0163

Hispanics

9

68 (54 – 79)

6/9 (66.66%)

0/9 (0%)

0.3573

Asians

3

63 (59 – 68)

3/3 (100%)

1/3 (33.33%)

0.4191

Native-American

1

70

1/1 (100%)

0/1 (0%)

—

Unidentified

2

83.5 (72 – 95)

0/2 (0%)

1/2 (50%)

—


Disclosure: A. Haikal, None; G. Fraga, None; J. Springer, None; M. Maz, None.

To cite this abstract in AMA style:

Haikal A, Fraga G, Springer J, Maz M. A Single Center Experience of Temporal Artery Biopsies Performed in 30 African American Patients [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/a-single-center-experience-of-temporal-artery-biopsies-performed-in-30-african-american-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-single-center-experience-of-temporal-artery-biopsies-performed-in-30-african-american-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology